References for Information - Parabens, etc.

References:

1. Fitzpatrick RE, Rostan EF. Double-blind, half-face study comparing topical vitamin C and vehicle for rejuvenation of photodamage. Dermatol Surg 2002;28:231-236.

2. Nusgens BV, Humbert P, Rougier A, et al. Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. J Invest Dermatol 2001 Jun;116(6):853-859.

3. Farris PK. Topical vitamin C: a useful agent for treating photoaging and other dermatologic conditions. Dermatol Surg 2005;31:814-818.

4. Carcamo JM, Pedrazza A, Borquez-Ojeda O, et al. Vitamin C suppresses TNF alpha-induced NK kappa B activation by inhibiting I kappa B alpha phosphorylation. Biochemistry 2002;41:12995-300002.

5. Senftleben U, Karin M. The Ikk/NF-B pathway. Crit Care Med 2002;30S18-26.

6. Alster TS, West TB. Effect of topical vitamin C on postoperative carbon dioxide laser resurfacing erythema. Dermatol Surg 1998;24:331-334.

7. Mustoe TA. Evolution of silicone therapy and mechanism of action in scar management. Aesth Plast Surg 2008;32:82–92.

8. Chan KY, Lau CL, Adeeb SM, et al. A randomized, placebo-controlled, double-blind, pro-spective clinical trial of silicone gel in prevention of hypertrophic scar development in median sternotomy wound. Plast Reconstr Surg 2005;116:1013–1020.

9. Kuhn, M. A., Moffit, M. R., Smith, P. D., et al. Silicone sheeting decreases fibroblast activity and downregulates TGFbeta2 in hypertrophic scar model. Int. J Surg Invest 2: 467, 2001.

10. Davis RH, DiDonato JJ, Hartman GM, et al. Anti-inflammatory and wound healing activity of a growth substance in Aloe vera. J Am Podiatr Med Assoc 1994;84(2):77-81.

11. Davis RH, Rosenthal KY, Cesario LR, Rouw GA. Processed Aloe vera administered topically inhibits inflammation. J Am Podiatr Med Assoc 1989;79(8):395-7.

12. Jelenko C, Wheeler ML, Scott TH. Etyl linoleate: the water-holding lipid of skin. Effects on in vivo burn scar. J Trauma 1972;12;974-982.

13. Ando H, Ryu A, Hashimoto A, et al. Linoleic acid and alpha-linolenic acid lightens ultraviolet-induced hyperpigmentation of the skin. Arch Dermatol Res. 1998 Jul;290(7):375-81.

14. Goldyne ME. Prostaglandins and cutaneous inflammation. J Invest Dermatol 1975;64:377-385.

15. Greaves MW. Prostaglandins and the epidermis. Br J Dermatol 1972;87:161-170.

16. Declair V. The usefulness of topical application of essential fatty acid (EFA) to prevent pressure ulcers. Ostomy Wound Manage 1997;43(5):48-54.

17. Cardoso CR, Souza MA, Ferro EA, Favoreto S Jr, Pena JD. Influence of topical administration of n-3 and n-6 essential and n-9 nonessential fatty acids on the healing of cutaneous wounds. Wound Repair Regen. 2004 Mar-Apr;12(2):235-43.

18. Yokota T, Nishio H, Kubota Y, Mizoguchi M. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res. 1998 Dec;11(6):355-61.

19. Tsukahara M, Nishino T, Furuhashi I, Inoue H, Sato T, Matsumoto H. Synthesis and inhibitory effect of novel glycyrrhetinic acid derivatives on IL-1 beta-induced prostaglandin E(2) production in normal human dermal fibroblasts. Chem Pharm Bull (Tokyo). 2005 Sep;53(9):1103-10.

20. Amer M, Metwalli M. Topical liquiritin improves melasma. Int J Dermatol. 2000 Apr;39(4):299-301.

21. Fu B, Li H, Wang X, Lee FS, Cui S. Isolation and identification of flavonoids in licorice and a study of their inhibitory effects on tyrosinase. J Agric Food Chem. 2005 Sep 21;53(19):7408-14.

22. Nam C, Kim S, Sim Y, Chang I. Anti-acne effects of Oriental herb extracts: a novel screening method to select anti-acne agents. Skin Pharmacol Appl Skin Physiol. 2003 Mar-Apr;16(2):84-90.

23. Lundov MD, Moesby L, Zachariae C, et al. Contamination versus preservation of cosmetics: a review on legislation, usage, infections, and contact allergy. Contact Dermatitis 2009 Feb;60(2):70-8.

24. Darbre, PD, Aljarrah, A., Miller, WR., et al. Concentrations of parabens in human breast tumors. J Appl Toxicol. Jan 2004: (24): 5-13.

25. Harvey, PW, Darbre PD, Endocrine disruptors and human health: Could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women? A review of evidence and call for further research. J Appl Toxicol. Jan 2004: (24): 167-176.

26. Darbre PD, Harvey PW. Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J Appl Toxicol. 2008 Jul;28(5):561-78.

27. Diepgen TL, Weisshaar E. Contact dermatitis: epidemiology and frequent sensitizers in cosmetics.
J Eur Acad Dermatol Venereol 2007 Sep;21(2):9-13.

28. Kooyers TJ, Westerhof W. Toxicological aspects and health risks associated with hydroquinone in skin bleaching formula. Ned Tijdschr Geneeskd. 2004 Apr 17;148(16):768-71

MORE REFERENCES:

References:

1. Zurada JM, Kriegel D, Davis IC. Topical treatments for hypertrophic scars. J Am Acad Dermatol 2006 Dec;55(6):1024-31.

2. Khoosal D, Goldman RD. Vitamin E for treating children’s scars. Does it help reduce scarring? Can Fam Physician 2006 Jul;52:855-6.

3. Kooyers TJ, Westerhof W. Toxicological aspects and health risks associated with hydroquinone in skin bleaching formula. Ned Tijdschr Geneeskd. 2004 Apr 17;148(16):768-71

4. Lundov MD, Moesby L, Zachariae C, et al. Contamination versus preservation of cosmetics: a review on legislation, usage, infections, and contact allergy. Contact Dermatitis 2009 Feb;60(2):70-8.

5. Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MJ, Pope GS. Concentrations of parabens in human breast tumours. J Appl Toxicol. 2004 Jan-Feb;24(1):5-13